abstracts |
[]
|
container |
{'state': 'active', 'ident': 'aowhseoqprea3b5rljynk52q4m', 'revision': 'd1ec6442-5860-406c-b4e7-773220ee677c', 'redirect': None, 'extra': {'abbrev': 'Nat. Med.', 'country': 'gb', 'ezb': {'color': 'red', 'ezb_id': '2962'}, 'kbart': {'clockss': {'year_spans': []}, 'hathitrust': {'year_spans': []}, 'portico': {'year_spans': [[1995, 2022]]}}, 'publisher_type': 'big5', 'sherpa_romeo': {'color': 'yellow'}, 'urls': ['http://www.nature.com/nm/', 'http://www.nature.com/nm/index.html']}, 'edit_extra': None, 'name': 'Nature Medicine', 'container_type': None, 'publication_status': None, 'publisher': 'Springer Science and Business Media LLC', 'issnl': '1078-8956', 'issne': '1546-170X', 'issnp': '1078-8956', 'wikidata_qid': 'Q1633234'}
|
container_id |
aowhseoqprea3b5rljynk52q4m
|
contribs |
[]
|
ext_ids |
{'doi': '10.1038/s41591-022-01716-3', 'wikidata_qid': None, 'isbn13': None, 'pmid': '35241843', 'pmcid': None, 'core': None, 'arxiv': None, 'jstor': None, 'ark': None, 'mag': None, 'doaj': None, 'dblp': None, 'oai': None, 'hdl': None}
|
files[] |
{'state': 'active', 'ident': 'smxctca2krhxlca23lpfwnwcym', 'revision': '1a8a89c0-2fc6-4fb9-b9be-468f0ea5f92e', 'redirect': None, 'extra': None, 'edit_extra': None, 'size': 786848, 'md5': '5f0ea9e3401e74983b0de9226f8e4bae', 'sha1': '5098fb091f6d58b210ebb7c6f6436a6322425567', 'sha256': '7cef9d5d42f06b7f444097da279e6b2102784aff55195c97e75a8bcf5adca786', 'urls': [{'url': 'https://www.nature.com/articles/s41591-022-01716-3.pdf', 'rel': 'publisher'}, {'url': 'https://web.archive.org/web/20220405070739/https://www.nature.com/articles/s41591-022-01716-3.pdf', 'rel': 'webarchive'}], 'mimetype': 'application/pdf', 'content_scope': None, 'release_ids': ['bxwuk5a3krdhjhxgyauiwkjvfe'], 'releases': None}
|
filesets |
[]
|
issue |
|
language |
en
|
license_slug |
|
number |
|
original_title |
|
pages |
|
publisher |
Springer Science and Business Media LLC
|
refs[] |
{'index': 0, 'target_release_id': None, 'extra': {'authors': ['A Shastri'], 'doi': '10.1182/blood-2016-10-696062', 'unstructured': 'Shastri, A., Will, B., Steidl, U. & Verma, A. Stem and progenitor cell alterations in myelodysplastic syndromes. Blood 129, 1586–1594 (2017). A review article that describes the alterations in stem and progenitor cells in MDSs.', 'volume': '129'}, 'key': '1716_CR1', 'year': 2017, 'container_name': 'Blood', 'title': None, 'locator': '1586'}
{'index': 1, 'target_release_id': None, 'extra': {'authors': ['AS Sperling'], 'doi': '10.1038/nrc.2016.112', 'unstructured': 'Sperling, A. S., Gibson, C. J. & Ebert, B. L. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat. Rev. Cancer 17, 5–19 (2017). A review article that summarizes the genetic aberrations at various stages of MDSs.', 'volume': '17'}, 'key': '1716_CR2', 'year': 2017, 'container_name': 'Nat. Rev. Cancer', 'title': None, 'locator': None}
{'index': 2, 'target_release_id': None, 'extra': {'authors': ['G Garcia-Manero'], 'doi': '10.1097/cco.0b013e328313699c', 'unstructured': 'Garcia-Manero, G. Demethylating agents in myeloid malignancies. Curr. Opin. Oncol. 20, 705–710 (2008). A review article that summarizes the initial discovery that HMA therapy can improve the survival of patients with MDSs.', 'volume': '20'}, 'key': '1716_CR3', 'year': 2008, 'container_name': 'Curr. Opin. Oncol.', 'title': None, 'locator': '705'}
{'index': 3, 'target_release_id': None, 'extra': {'authors': ['TM Kadia'], 'doi': '10.1053/j.seminoncol.2011.04.011', 'unstructured': 'Kadia, T. M., Jabbour, E. & Kantarjian, H. Failure of hypomethylating agent-based therapy in myelodysplastic syndromes. Semin. Oncol. 38, 682–692 (2011). A paper that reports the survival of patients with MDSs after HMA therapy failure.', 'volume': '38'}, 'key': '1716_CR4', 'year': 2011, 'container_name': 'Semin. Oncol.', 'title': None, 'locator': '682'}
{'index': 4, 'target_release_id': None, 'extra': {'authors': ['J Chen'], 'doi': '10.1038/s41591-018-0267-4', 'unstructured': 'Chen, J. et al. Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level. Nat. Med. 25, 103–110 (2019). A paper reporting that MDS progression arises from the HSC compartment.', 'volume': '25'}, 'key': '1716_CR5', 'year': 2019, 'container_name': 'Nat. Med.', 'title': None, 'locator': '103'}
|
release_date |
2022-03-03
|
release_stage |
published
|
release_type |
article-journal
|
release_year |
2022
|
subtitle |
|
title |
Overcoming myelodysplastic syndrome progression after frontline therapy
|
version |
|
volume |
|
webcaptures |
[]
|
withdrawn_date |
|
withdrawn_status |
|
withdrawn_year |
|
work_id |
jdw67lxvvjatnpoozv5dq6fpfq
|